文献速递流行病学与生物统计真实世界研究与卫生经济医学人工智能与信息学

核心结局指标集贯穿医疗生态系统:以2型糖尿病为例

Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus.
PubMed 文献 · Trials · 2020-06-25

该研究以2型糖尿病为案例,比较了研究用核心结局指标集(COS)与常规护理、监管机构指南、质量指标、电子健康记录(EHR)及床旁随机临床试验中结局的重叠程度。结果显示,2型糖尿病的重要患者结局在研究与实践间高度一致,且英国全科EHR有相应覆盖。这表明EHR纳入COS可促进高效研究与价值医疗,但该一致性可能不适用于其他疾病。

要点

  • 2型糖尿病的研究与医疗结局指标高度一致,且被英国全科EHR覆盖。
  • EHR纳入COS有望提升研究效率并支持价值医疗。
  • 该一致性可能因疾病而异,2型糖尿病或更侧重患者中心结局。

核心结论

  • 以2型糖尿病为例,研究与医疗的重要患者结局高度一致,且相关结局在英国全科EHR中有覆盖。
  • 若EHR能纳入涵盖所有利益相关方重要结局的COS,有望实现高效研究与价值医疗。
  • 该一致性可能不具普遍性,因2型糖尿病对患者中心结局的关注可能高于其他疾病。

研究设计与样本

  • 以2型糖尿病为案例的对比研究,比较研究用COS与常规护理、EMA、FDA、NICE指南、NICE质量声明/指标、EHR及床旁随机临床试验中结局的重叠程度。

主要发现

  • 2型糖尿病研究与医疗的重要患者结局存在实质性一致,并在英国全科EHR中有相应覆盖。

临床怎么用

  • 可考虑将COS同时嵌入研究与常规护理的EHR,以支持高效研究和价值医疗。

局限性

  • 2型糖尿病对患者中心结局的关注可能高于其他疾病,结论推广需谨慎。
  • 其他临床领域的类似分析正在进行,以揭示结局不一致时的低效问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is increasingly accepted that insufficient attention has been given to the patient health outcomes that are important to measure in comparative effectiveness research that will inform decision-making. The relationship between outcomes chosen for comparative effectiveness research, outcomes used in decision-making in routine care, and outcome data recorded in electronic health records (EHR) is also poorly understood. The COMET Initiative (http://www.comet-initiative.org/. Accessed 3 Apr 2020) supports and encourages the development and use of 'core outcome sets' (COS), which represent the minimum set of patient health outcomes that should be measured and reported for a specific condition. There is growing interest in identifying how COS might fit into the different stages of the healthcare research and delivery ecosystem, and whether inclusion in the EHR might facilitate this. METHODS: We sought to determine the degree of overlap between outcomes within COS for research and routine care, EMA, FDA and NICE guidelines, NICE quality statements/indicators, EHR and a point-of-care randomised clinical trial, using type 2 diabetes (T2D) as a case study. RESULTS: There is substantial agreement about important patient outcomes for T2D for research and healthcare, with associated coverage within the UK general practice EHR. CONCLUSIONS: This case study has demonstrated the potential for efficient research and value-based healthcare when the EHR can include COS for both research and care, where the COS comprises outcomes of importance to all relevant stakeholders. However, this concordance may not hold more generally, as the focus on patient-centred outcomes may well be greater in T2D than in other conditions. Work is ongoing to examine other clinical areas, in order to highlight any current inefficiencies when health outcomes in research and healthcare do not agree with core outcomes identified by patients, clinicians and other key stakeholders.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Dodd S, Harman N, Taske N, et al. Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus. Trials. 2020. PMID: 32586349. doi:10.1186/s13063-020-04403-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。